Literature DB >> 8794287

YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity.

M J O'Connor1, S H Tan, C H Tan, H U Bernard.   

Abstract

YY1 is a multifunctional transcription factor that has been shown to regulate the expression of a number of cellular and viral genes, including the human papillomavirus (HPV) oncogenes E6 and E7. In this study, we have analyzed the YY1-mediated repression of the HPV type 16 (HPV-16) E6-E7 promoter. A systematic analysis to identify YY1 sites present in the HPV-16 long control region showed that of 30 potential YY1 binding motifs, 24 bound purified recombinant YY1 protein, but only 10 of these were able to bind YY1 when nuclear extracts of HeLa cells were used. Of these, only a cluster of five sites, located in the vicinity of an AP-1 motif, were found to be responsible for repressing the HPV-16 P97 promoter. All five sites were required for repression, the mutation of any one site giving rise to a four- to sixfold increase in transcriptional activity. The target for YY1-mediated repression was identified as being a highly conserved AP-1 site, and we propose that AP-1 may represent a common target for YY1 repression. We also provide data demonstrating that YY1 can bind the transcriptional coactivator CREB-binding protein and propose a potentially novel mechanism by which YY1 represses AP-1 activity as a result of this YY1-CREB-binding protein interaction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794287      PMCID: PMC190693     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein.

Authors:  Y Shi; E Seto; L S Chang; T Shenk
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

2.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

3.  The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.

Authors:  S H Tan; L E Leong; P A Walker; H U Bernard
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16.

Authors:  G J Sibbet; M S Campo
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

5.  Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: evidence for promoter usage within the E7 open reading frame during epithelial differentiation.

Authors:  G D Higgins; D M Uzelin; G E Phillips; P McEvoy; R Marin; C J Burrell
Journal:  J Gen Virol       Date:  1992-08       Impact factor: 3.891

6.  Phosphorylated CREB binds specifically to the nuclear protein CBP.

Authors:  J C Chrivia; R P Kwok; N Lamb; M Hagiwara; M R Montminy; R H Goodman
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

7.  Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus.

Authors:  J R Flanagan; K G Becker; D L Ennist; S L Gleason; P H Driggers; B Z Levi; E Appella; K Ozato
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

8.  Functional antagonism between YY1 and the serum response factor.

Authors:  A Gualberto; D LePage; G Pons; S L Mader; K Park; M L Atchison; K Walsh
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

9.  The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.

Authors:  B Gloss; H U Bernard; K Seedorf; G Klock
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

10.  CBP-induced stimulation of c-Fos activity is abrogated by E1A.

Authors:  A J Bannister; T Kouzarides
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more
  43 in total

1.  Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.

Authors:  M J O'Connor; H Zimmermann; S Nielsen; H U Bernard; T Kouzarides
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.

Authors:  Wei-Ming Wang; Shwu-Yuan Wu; A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

3.  The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element.

Authors:  M J O'Connor; W Stünkel; C H Koh; H Zimmermann; H U Bernard
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.

Authors:  K J Watts; C H Thompson; Y E Cossart; B R Rose
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 5.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

6.  Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses.

Authors:  S H Tan; D Bartsch; E Schwarz; H U Bernard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.

Authors:  W Zhao; L T Chow; T R Broker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  Multiple mechanisms of transcriptional repression by YY1.

Authors:  K M Galvin; Y Shi
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 9.  Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.

Authors:  Megan A Clarke; Nicolas Wentzensen; Lisa Mirabello; Arpita Ghosh; Sholom Wacholder; Ariana Harari; Attila Lorincz; Mark Schiffman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

10.  The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression.

Authors:  W Stünkel; H U Bernard
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.